- £1.49bn
- £1.60bn
- £3.95bn
- 82
- 63
- 90
- 93
R2019 March 31st | 2020 March 31st | R2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,085 | 2,174 | 2,499 | 3,903 | 3,945 |
Cost of Revenue | |||||
Gross Profit | 282 | 288 | 276 | 452 | 437 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,044 | 2,109 | 2,495 | 3,831 | 3,828 |
Operating Profit | 41.7 | 64.6 | 4 | 72.1 | 117 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 28 | 48.4 | -13.7 | 52.3 | 106 |
Provision for Income Taxes | |||||
Net Income After Taxes | 22.6 | 40.5 | -14.1 | 31.3 | 91.1 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 30.9 | 90.5 | -6.9 | 50.7 | 91.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 30.9 | 90.5 | -6.9 | 50.7 | 91.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.097 | 0.093 | 0.056 | 0.082 | 0.098 |
Dividends per Share |